The consent form clearly stated there was no direct benefit to me but the indirect benefit is I am learn whether I am likely to relapse or not and the lenalidomide could stall that for a while.
As far as the chimerism test, this isn't the one that is done routinely after a transplant. It was one that was developed at UF Health and is supposed to be much more accurate and predict relapse.
Prostate Cancer: Treated in early 2013 with HDR Brachytherapy. MDS-RCMD: Oct 2014. Biopsies: 46,XY,t(7;18): 46,XY,del(7)( q22): 45,XY,-7: 45,XY,-7: 45,XY,-7. HSCT in April 2016.
Last edited by Data : Fri May 27, 2016 at 03:37 PM.